S. Marchand‐Adam

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

Athol U. Wells, Kevin R. Flaherty, Kevin K. Brown et al. · The Lancet Respiratory Medicine · 2020 · 522 citations · Full text

Inbuild Trial, Parallel-group Trial, Advanced Lung Disease +5

<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease

Pierre‐Antoine Juge, Joyce Lee, Esther Ebstein et al. · New England Journal of Medicine · 2018 · 475 citations · Full text

Extracellular ATP Is a Danger Signal Activating P2X ₇ Receptor in Lung Inflammation and Fibrosis

Nicolas Riteau, Paméla Gasse, Louis Fauconnier et al. · American Journal of Respiratory and Critical Care Medicine · 2010 · 397 citations

[Interstitial lung disease in connective tissue disorders].

D. Carmier, Élisabeth Diot, Laurent Guilleminault et al. · PubMed · 2014 · 239 citations

Asthma, Rheumatology, Translational Medicine +15

Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis

Pierre‐Antoine Juge, Raphaël Borie, Caroline Kannengiesser et al. · European Respiratory Journal · 2017 · 225 citations · Full text